Advertisements



We are Sorry, This Page doesn't Exist


Merck"s stock surges after positive Keytruda trial results

Shares of Merck & Co. Inc. surged 2.6% in premarket trade Monday, after the drug maker said its cancer treatment Keytruda met the primary endpoint of a phase 3 trial evaluating the Keytr.....»»

Category: topSource: marketwatchApr 9th, 2018

Eli Lilly reports positive results in late-stage trial of liver cancer treatment

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 4th, 2018

Eli Lilly reports positive results in late-stage trial of liver cancer treatment

Eli Lilly and Co. said Wednesday a late-stage trial of a liver cancer treatment met its main goals. The company said patients in a pha.....»»

Category: topSource: marketwatchApr 4th, 2018

UPDATE: Merck shares jump 7% on news of positive results from lung cancer trial

Merck & Co. Inc. shares jumped almost 7% Tuesday, after the company announced positive results in a late-stage lung cancer trial. The New Jersey-based drug company said the Phase 3 trial of Keytruda in combination with pemetrexed and cisp.....»»

Category: topSource: marketwatchJan 16th, 2018

UPDATE: Merck shares jump 5% on news of positive results from lung cancer trial

Merck & Co. Inc. shares jumped 5% premarket Tuesday, after the company announced positive results in a late-stage lung cancer trial. The New Jersey-based drug.....»»

Category: topSource: marketwatchJan 16th, 2018

Revance stock surges 33% on positive results for wrinkle injection in late-stage trials

Revance Therapeutics Inc. shares surged nearly 33% in premarket trade on Tuesday after the comp.....»»

Category: topSource: marketwatchDec 5th, 2017

AbbVie"s stock climbs after positive late-stage trial results of psoriasis treatment

Shares of AbbVie Inc......»»

Category: topSource: marketwatchDec 4th, 2017

Eli Lilly"s stock sinks after disappointing results from late-stage trial of cancer treatment

Shares of Eli Lilly & Co. sank 4.2% in premarket trade .....»»

Category: topSource: marketwatchOct 10th, 2017

UPDATE: Nabriva Therapeutics stock jumps 102% premarket on positive trial of pneumonia treatment

Nabriva Therapeutics plc shares surged 102% in premarket trade Monday, after the company reported positive results from a late-stage trial of a treatment for community-acquired bacterial pneumonia, or CAB.....»»

Category: topSource: marketwatchSep 18th, 2017

UPDATE: Nabriva Therapeutics stock jumps 82% premarket on positive trial of pneumonia treatment

Nabriva Therapeutics plc shares surged 82% in premarket trade Monday, after the company reported positive results from a late-stage trial of a treatment for community-acquired bacterial pneumonia, or CAB.....»»

Category: topSource: marketwatchSep 18th, 2017

Kura Oncology"s stock rockets after positive results from cancer treatment trial

Shares of Kura Oncology Inc. rocketed 26% in premarket trade F.....»»

Category: topSource: marketwatchSep 8th, 2017

Merck shares rise 2.7% on late-stage lung cancer trial results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 16th, 2018

AbbVie shares jump 2.2% on news of positive results in rheumatoid arthritis drug trial

Shares of AbbVie Inc. jumped 2.2% in premarket trade Monday, after the company reported positive results in a late-stage trial of a treatment for rheumatoid arthritis. AbbVie said the phase 3 trial of upadacitinib met its primary endpoints. Upadaciti.....»»

Category: topSource: marketwatchApr 9th, 2018

Incyte stock plummets following disappointed clinical study results

Incyte Corp.’s stock price plunged nearly 20 percent Friday after the Wilmington biotechnology company announced disappointing late-stage study results for an experimental cancer therapy. The results from a phase-III clinical study, testing Inc.....»»

Category: topSource: bizjournalsApr 6th, 2018

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Pfizer shares took a small step back on Monday despite announcing positive results from a late-stage trial. The pullback seems to be the product of overall market sentiment as opposed to these........»»

Category: blogSource: 247wallstApr 2nd, 2018

Alexion Wins Big in Late-Stage Trial

Alexion Pharmaceuticals watched its shares make a solid gain on Thursday after the firm announced positive results from its late-stage trial of ALXN1210......»»

Category: blogSource: 247wallstMar 15th, 2018

UPDATE: Esperion reports positive results in late-stage trial of heart disease treatment , shares jump 4%

Esperion Thera.....»»

Category: topSource: marketwatchMar 7th, 2018

Esperion reports positive results in late-stage trial of heart disease treatment

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 7th, 2018

Why Clearside BioMedical Is Monday’s Biggest Winner

Clearside BioMedical saw its shares make an incredible gain to start the week after the firm announced positive topline results from its late-stage trial......»»

Category: blogSource: 247wallstMar 5th, 2018

Clearside Biomedical shares surge 53% premarket on news of positive trial of eye disease treatment

Clearside Biomedical Inc. shares surged 53% in premarket trade Monday, after the company announced positive results in a late-stage trial of a treatment for macular edema associated with non-infectious uveitis, a swelling tha.....»»

Category: topSource: marketwatchMar 5th, 2018